カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界のダサチニブ医薬品市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Dasatinib Drugs Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO19256）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO19256
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：75
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界のダサチニブ医薬品市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

ダサチニブ医薬品市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のダサチニブ医薬品の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

ダサチニブ医薬品市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・20mg、50mg、70mg

用途別セグメントは次のように区分されます。
・CML、ALL

世界のダサチニブ医薬品市場の主要な市場プレーヤーは以下のとおりです。
・Bristol-Myers Squibb、LUCIUS Pharma

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、ダサチニブ医薬品製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なダサチニブ医薬品メーカーの企業概要、2019年～2022年までのダサチニブ医薬品の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なダサチニブ医薬品メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別ダサチニブ医薬品の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのダサチニブ医薬品の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのダサチニブ医薬品市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびダサチニブ医薬品の産業チェーンを掲載しています。
・第13、14、15章では、ダサチニブ医薬品の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- ダサチニブ医薬品の概要
- 種類別分析（2017年vs2021年vs2028年）：20mg、50mg、70mg
- 用途別分析（2017年vs2021年vs2028年）：CML、ALL
- 世界のダサチニブ医薬品市場規模・予測
- 世界のダサチニブ医薬品生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Bristol-Myers Squibb、LUCIUS Pharma
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：20mg、50mg、70mg
・用途別分析2017年-2028年：CML、ALL
・ダサチニブ医薬品の北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・ダサチニブ医薬品のヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・ダサチニブ医薬品のアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・ダサチニブ医薬品の南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・ダサチニブ医薬品の中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Dasatinib Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Dasatinib Drugs market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. CML accounting for % of the Dasatinib Drugs global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While 20mg segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Dasatinib Drugs include Bristol-Myers Squibb, LUCIUS Pharma, , , and , etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Dasatinib Drugs market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
20mg
50mg
70mg
Market segment by Application can be divided into
CML
ALL
The key market players for global Dasatinib Drugs market are listed below:
Bristol-Myers Squibb
LUCIUS Pharma
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Dasatinib Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Dasatinib Drugs, with price, sales, revenue and global market share of Dasatinib Drugs from 2019 to 2022.
Chapter 3, the Dasatinib Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Dasatinib Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Dasatinib Drugs market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Dasatinib Drugs.
Chapter 13, 14, and 15, to describe Dasatinib Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Dasatinib Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Dasatinib Drugs Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 20mg
1.2.3 50mg
1.2.4 70mg
1.3 Market Analysis by Application
1.3.1 Overview: Global Dasatinib Drugs Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 CML
1.3.3 ALL
1.4 Global Dasatinib Drugs Market Size & Forecast
1.4.1 Global Dasatinib Drugs Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Dasatinib Drugs Sales in Volume (2017-2028)
1.4.3 Global Dasatinib Drugs Price (2017-2028)
1.5 Global Dasatinib Drugs Production Capacity Analysis
1.5.1 Global Dasatinib Drugs Total Production Capacity (2017-2028)
1.5.2 Global Dasatinib Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Dasatinib Drugs Market Drivers
1.6.2 Dasatinib Drugs Market Restraints
1.6.3 Dasatinib Drugs Trends Analysis
2 Manufacturers Profiles
2.1 Bristol-Myers Squibb
2.1.1 Bristol-Myers Squibb Details
2.1.2 Bristol-Myers Squibb Major Business
2.1.3 Bristol-Myers Squibb Dasatinib Drugs Product and Services
2.1.4 Bristol-Myers Squibb Dasatinib Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 LUCIUS Pharma
2.2.1 LUCIUS Pharma Details
2.2.2 LUCIUS Pharma Major Business
2.2.3 LUCIUS Pharma Dasatinib Drugs Product and Services
2.2.4 LUCIUS Pharma Dasatinib Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Dasatinib Drugs Breakdown Data by Manufacturer
3.1 Global Dasatinib Drugs Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Dasatinib Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Dasatinib Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Dasatinib Drugs Manufacturer Market Share in 2021
3.4.2 Top 6 Dasatinib Drugs Manufacturer Market Share in 2021
3.5 Global Dasatinib Drugs Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Dasatinib Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Dasatinib Drugs Market Size by Region
4.1.1 Global Dasatinib Drugs Sales in Volume by Region (2017-2028)
4.1.2 Global Dasatinib Drugs Revenue by Region (2017-2028)
4.2 North America Dasatinib Drugs Revenue (2017-2028)
4.3 Europe Dasatinib Drugs Revenue (2017-2028)
4.4 Asia-Pacific Dasatinib Drugs Revenue (2017-2028)
4.5 South America Dasatinib Drugs Revenue (2017-2028)
4.6 Middle East and Africa Dasatinib Drugs Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Dasatinib Drugs Sales in Volume by Type (2017-2028)
5.2 Global Dasatinib Drugs Revenue by Type (2017-2028)
5.3 Global Dasatinib Drugs Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Dasatinib Drugs Sales in Volume by Application (2017-2028)
6.2 Global Dasatinib Drugs Revenue by Application (2017-2028)
6.3 Global Dasatinib Drugs Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Dasatinib Drugs Sales by Type (2017-2028)
7.2 North America Dasatinib Drugs Sales by Application (2017-2028)
7.3 North America Dasatinib Drugs Market Size by Country
7.3.1 North America Dasatinib Drugs Sales in Volume by Country (2017-2028)
7.3.2 North America Dasatinib Drugs Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Dasatinib Drugs Sales by Type (2017-2028)
8.2 Europe Dasatinib Drugs Sales by Application (2017-2028)
8.3 Europe Dasatinib Drugs Market Size by Country
8.3.1 Europe Dasatinib Drugs Sales in Volume by Country (2017-2028)
8.3.2 Europe Dasatinib Drugs Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Dasatinib Drugs Sales by Type (2017-2028)
9.2 Asia-Pacific Dasatinib Drugs Sales by Application (2017-2028)
9.3 Asia-Pacific Dasatinib Drugs Market Size by Region
9.3.1 Asia-Pacific Dasatinib Drugs Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Dasatinib Drugs Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Dasatinib Drugs Sales by Type (2017-2028)
10.2 South America Dasatinib Drugs Sales by Application (2017-2028)
10.3 South America Dasatinib Drugs Market Size by Country
10.3.1 South America Dasatinib Drugs Sales in Volume by Country (2017-2028)
10.3.2 South America Dasatinib Drugs Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Dasatinib Drugs Sales by Type (2017-2028)
11.2 Middle East & Africa Dasatinib Drugs Sales by Application (2017-2028)
11.3 Middle East & Africa Dasatinib Drugs Market Size by Country
11.3.1 Middle East & Africa Dasatinib Drugs Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Dasatinib Drugs Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Dasatinib Drugs and Key Manufacturers
12.2 Manufacturing Costs Percentage of Dasatinib Drugs
12.3 Dasatinib Drugs Production Process
12.4 Dasatinib Drugs Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Dasatinib Drugs Typical Distributors
13.3 Dasatinib Drugs Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Dasatinib Drugs Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Dasatinib Drugs Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 4. Bristol-Myers Squibb Major Business
Table 5. Bristol-Myers Squibb Dasatinib Drugs Product and Services
Table 6. Bristol-Myers Squibb Dasatinib Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. LUCIUS Pharma Basic Information, Manufacturing Base and Competitors
Table 8. LUCIUS Pharma Major Business
Table 9. LUCIUS Pharma Dasatinib Drugs Product and Services
Table 10. LUCIUS Pharma Dasatinib Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Global Dasatinib Drugs Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 12. Global Dasatinib Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 13. Market Position of Manufacturers in Dasatinib Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 14. Global Dasatinib Drugs Production Capacity by Company, (K Units): 2020 VS 2021
Table 15. Head Office and Dasatinib Drugs Production Site of Key Manufacturer
Table 16. Dasatinib Drugs New Entrant and Capacity Expansion Plans
Table 17. Dasatinib Drugs Mergers & Acquisitions in the Past Five Years
Table 18. Global Dasatinib Drugs Sales by Region (2017-2022) & (K Units)
Table 19. Global Dasatinib Drugs Sales by Region (2023-2028) & (K Units)
Table 20. Global Dasatinib Drugs Revenue by Region (2017-2022) & (USD Million)
Table 21. Global Dasatinib Drugs Revenue by Region (2023-2028) & (USD Million)
Table 22. Global Dasatinib Drugs Sales by Type (2017-2022) & (K Units)
Table 23. Global Dasatinib Drugs Sales by Type (2023-2028) & (K Units)
Table 24. Global Dasatinib Drugs Revenue by Type (2017-2022) & (USD Million)
Table 25. Global Dasatinib Drugs Revenue by Type (2023-2028) & (USD Million)
Table 26. Global Dasatinib Drugs Price by Type (2017-2022) & (USD/Unit)
Table 27. Global Dasatinib Drugs Price by Type (2023-2028) & (USD/Unit)
Table 28. Global Dasatinib Drugs Sales by Application (2017-2022) & (K Units)
Table 29. Global Dasatinib Drugs Sales by Application (2023-2028) & (K Units)
Table 30. Global Dasatinib Drugs Revenue by Application (2017-2022) & (USD Million)
Table 31. Global Dasatinib Drugs Revenue by Application (2023-2028) & (USD Million)
Table 32. Global Dasatinib Drugs Price by Application (2017-2022) & (USD/Unit)
Table 33. Global Dasatinib Drugs Price by Application (2023-2028) & (USD/Unit)
Table 34. North America Dasatinib Drugs Sales by Country (2017-2022) & (K Units)
Table 35. North America Dasatinib Drugs Sales by Country (2023-2028) & (K Units)
Table 36. North America Dasatinib Drugs Revenue by Country (2017-2022) & (USD Million)
Table 37. North America Dasatinib Drugs Revenue by Country (2023-2028) & (USD Million)
Table 38. North America Dasatinib Drugs Sales by Type (2017-2022) & (K Units)
Table 39. North America Dasatinib Drugs Sales by Type (2023-2028) & (K Units)
Table 40. North America Dasatinib Drugs Sales by Application (2017-2022) & (K Units)
Table 41. North America Dasatinib Drugs Sales by Application (2023-2028) & (K Units)
Table 42. Europe Dasatinib Drugs Sales by Country (2017-2022) & (K Units)
Table 43. Europe Dasatinib Drugs Sales by Country (2023-2028) & (K Units)
Table 44. Europe Dasatinib Drugs Revenue by Country (2017-2022) & (USD Million)
Table 45. Europe Dasatinib Drugs Revenue by Country (2023-2028) & (USD Million)
Table 46. Europe Dasatinib Drugs Sales by Type (2017-2022) & (K Units)
Table 47. Europe Dasatinib Drugs Sales by Type (2023-2028) & (K Units)
Table 48. Europe Dasatinib Drugs Sales by Application (2017-2022) & (K Units)
Table 49. Europe Dasatinib Drugs Sales by Application (2023-2028) & (K Units)
Table 50. Asia-Pacific Dasatinib Drugs Sales by Region (2017-2022) & (K Units)
Table 51. Asia-Pacific Dasatinib Drugs Sales by Region (2023-2028) & (K Units)
Table 52. Asia-Pacific Dasatinib Drugs Revenue by Region (2017-2022) & (USD Million)
Table 53. Asia-Pacific Dasatinib Drugs Revenue by Region (2023-2028) & (USD Million)
Table 54. Asia-Pacific Dasatinib Drugs Sales by Type (2017-2022) & (K Units)
Table 55. Asia-Pacific Dasatinib Drugs Sales by Type (2023-2028) & (K Units)
Table 56. Asia-Pacific Dasatinib Drugs Sales by Application (2017-2022) & (K Units)
Table 57. Asia-Pacific Dasatinib Drugs Sales by Application (2023-2028) & (K Units)
Table 58. South America Dasatinib Drugs Sales by Country (2017-2022) & (K Units)
Table 59. South America Dasatinib Drugs Sales by Country (2023-2028) & (K Units)
Table 60. South America Dasatinib Drugs Revenue by Country (2017-2022) & (USD Million)
Table 61. South America Dasatinib Drugs Revenue by Country (2023-2028) & (USD Million)
Table 62. South America Dasatinib Drugs Sales by Type (2017-2022) & (K Units)
Table 63. South America Dasatinib Drugs Sales by Type (2023-2028) & (K Units)
Table 64. South America Dasatinib Drugs Sales by Application (2017-2022) & (K Units)
Table 65. South America Dasatinib Drugs Sales by Application (2023-2028) & (K Units)
Table 66. Middle East & Africa Dasatinib Drugs Sales by Region (2017-2022) & (K Units)
Table 67. Middle East & Africa Dasatinib Drugs Sales by Region (2023-2028) & (K Units)
Table 68. Middle East & Africa Dasatinib Drugs Revenue by Region (2017-2022) & (USD Million)
Table 69. Middle East & Africa Dasatinib Drugs Revenue by Region (2023-2028) & (USD Million)
Table 70. Middle East & Africa Dasatinib Drugs Sales by Type (2017-2022) & (K Units)
Table 71. Middle East & Africa Dasatinib Drugs Sales by Type (2023-2028) & (K Units)
Table 72. Middle East & Africa Dasatinib Drugs Sales by Application (2017-2022) & (K Units)
Table 73. Middle East & Africa Dasatinib Drugs Sales by Application (2023-2028) & (K Units)
Table 74. Dasatinib Drugs Raw Material
Table 75. Key Manufacturers of Dasatinib Drugs Raw Materials
Table 76. Direct Channel Pros & Cons
Table 77. Indirect Channel Pros & Cons
Table 78. Dasatinib Drugs Typical Distributors
Table 79. Dasatinib Drugs Typical Customers
List of Figures
Figure 1. Dasatinib Drugs Picture
Figure 2. Global Dasatinib Drugs Revenue Market Share by Type in 2021
Figure 3. 20mg
Figure 4. 50mg
Figure 5. 70mg
Figure 6. Global Dasatinib Drugs Revenue Market Share by Application in 2021
Figure 7. CML
Figure 8. ALL
Figure 9. Global Dasatinib Drugs Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 10. Global Dasatinib Drugs Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Dasatinib Drugs Sales (2017-2028) & (K Units)
Figure 12. Global Dasatinib Drugs Price (2017-2028) & (USD/Unit)
Figure 13. Global Dasatinib Drugs Production Capacity (2017-2028) & (K Units)
Figure 14. Global Dasatinib Drugs Production Capacity by Geographic Region: 2022 VS 2028
Figure 15. Dasatinib Drugs Market Drivers
Figure 16. Dasatinib Drugs Market Restraints
Figure 17. Dasatinib Drugs Market Trends
Figure 18. Global Dasatinib Drugs Sales Market Share by Manufacturer in 2021
Figure 19. Global Dasatinib Drugs Revenue Market Share by Manufacturer in 2021
Figure 20. Dasatinib Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 21. Top 3 Dasatinib Drugs Manufacturer (Revenue) Market Share in 2021
Figure 22. Top 6 Dasatinib Drugs Manufacturer (Revenue) Market Share in 2021
Figure 23. Global Dasatinib Drugs Sales Market Share by Region (2017-2028)
Figure 24. Global Dasatinib Drugs Revenue Market Share by Region (2017-2028)
Figure 25. North America Dasatinib Drugs Revenue (2017-2028) & (USD Million)
Figure 26. Europe Dasatinib Drugs Revenue (2017-2028) & (USD Million)
Figure 27. Asia-Pacific Dasatinib Drugs Revenue (2017-2028) & (USD Million)
Figure 28. South America Dasatinib Drugs Revenue (2017-2028) & (USD Million)
Figure 29. Middle East & Africa Dasatinib Drugs Revenue (2017-2028) & (USD Million)
Figure 30. Global Dasatinib Drugs Sales Market Share by Type (2017-2028)
Figure 31. Global Dasatinib Drugs Revenue Market Share by Type (2017-2028)
Figure 32. Global Dasatinib Drugs Price by Type (2017-2028) & (USD/Unit)
Figure 33. Global Dasatinib Drugs Sales Market Share by Application (2017-2028)
Figure 34. Global Dasatinib Drugs Revenue Market Share by Application (2017-2028)
Figure 35. Global Dasatinib Drugs Price by Application (2017-2028) & (USD/Unit)
Figure 36. North America Dasatinib Drugs Sales Market Share by Type (2017-2028)
Figure 37. North America Dasatinib Drugs Sales Market Share by Application (2017-2028)
Figure 38. North America Dasatinib Drugs Sales Market Share by Country (2017-2028)
Figure 39. North America Dasatinib Drugs Revenue Market Share by Country (2017-2028)
Figure 40. United States Dasatinib Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Canada Dasatinib Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Mexico Dasatinib Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Europe Dasatinib Drugs Sales Market Share by Type (2017-2028)
Figure 44. Europe Dasatinib Drugs Sales Market Share by Application (2017-2028)
Figure 45. Europe Dasatinib Drugs Sales Market Share by Country (2017-2028)
Figure 46. Europe Dasatinib Drugs Revenue Market Share by Country (2017-2028)
Figure 47. Germany Dasatinib Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. France Dasatinib Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. United Kingdom Dasatinib Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Russia Dasatinib Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Italy Dasatinib Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Asia-Pacific Dasatinib Drugs Sales Market Share by Region (2017-2028)
Figure 53. Asia-Pacific Dasatinib Drugs Sales Market Share by Application (2017-2028)
Figure 54. Asia-Pacific Dasatinib Drugs Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Dasatinib Drugs Revenue Market Share by Region (2017-2028)
Figure 56. China Dasatinib Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Japan Dasatinib Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Korea Dasatinib Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. India Dasatinib Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Southeast Asia Dasatinib Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Australia Dasatinib Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South America Dasatinib Drugs Sales Market Share by Type (2017-2028)
Figure 63. South America Dasatinib Drugs Sales Market Share by Application (2017-2028)
Figure 64. South America Dasatinib Drugs Sales Market Share by Country (2017-2028)
Figure 65. South America Dasatinib Drugs Revenue Market Share by Country (2017-2028)
Figure 66. Brazil Dasatinib Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Argentina Dasatinib Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Middle East & Africa Dasatinib Drugs Sales Market Share by Type (2017-2028)
Figure 69. Middle East & Africa Dasatinib Drugs Sales Market Share by Application (2017-2028)
Figure 70. Middle East & Africa Dasatinib Drugs Sales Market Share by Region (2017-2028)
Figure 71. Middle East & Africa Dasatinib Drugs Revenue Market Share by Region (2017-2028)
Figure 72. Turkey Dasatinib Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Egypt Dasatinib Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Saudi Arabia Dasatinib Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. South Africa Dasatinib Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Manufacturing Cost Structure Analysis of Dasatinib Drugs in 2021
Figure 77. Manufacturing Process Analysis of Dasatinib Drugs
Figure 78. Dasatinib Drugs Industrial Chain
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • ダサチニブ薬のグローバル市場展望 2023年-2029年：20mg、50mg、70mg
  • 世界のオシメルチニブ医薬品市場2022年：市場規模予測（～2028年）
  • 世界のエクセナチド薬物市場2022年：市場規模予測（～2028年）
  • 世界のペガスパルガーゼ薬物市場2022年：市場規模予測（～2028年）
  • 世界のリロナセプト薬物市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO19256 )"世界のダサチニブ医薬品市場2022年：市場規模予測（～2028年）" (英文：Global Dasatinib Drugs Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。